Search research articles
Contact Us
Filters
Showing results (101-110 of 182) with videos related to
Page
of 19
Sort By:
Nature
|
November 13, 2009
Direct inhibition of the NOTCH transcription factor complex
Raymond E Moellering, Melanie Cornejo, Tina N Davis, et al.
The Journal of Clinical Investigation
|
March 10, 2007
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis
Claudia Scholl, Dimple Bansal, Konstanze Döhner, et al.
Molecular Cell
|
July 11, 2008
Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore
Kim De Keersmaecker, Jennifer L Rocnik, Rafael Bernad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 2006
Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model
Dimple Bansal, Claudia Scholl, Stefan Fröhling, et al.
Nature
|
July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.
Blood
|
March 24, 2005
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Joseph D Growney, Hirokazu Shigematsu, Zhe Li, et al.
Nature Medicine
|
July 27, 2004
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
Toshiyuki Araki, M Golam Mohi, Fraz A Ismat, et al.
Blood Advances
|
March 26, 2020
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling
Dana C Bellissimo, Chia-Hui Chen, Qin Zhu, et al.
Blood
|
January 8, 2003
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657
Jastinder Sohal, Vernon T Phan, Philip V Chan, et al.
Page
of 19
Search research articles
Search
Showing results (101-110 of 182) with videos related to
Sort By:
Page
of 19
Nature
|
November 13, 2009
Direct inhibition of the NOTCH transcription factor complex
Raymond E Moellering, Melanie Cornejo, Tina N Davis, et al.
The Journal of Clinical Investigation
|
March 10, 2007
The homeobox gene CDX2 is aberrantly expressed in most cases of acute myeloid leukemia and promotes leukemogenesis
Claudia Scholl, Dimple Bansal, Konstanze Döhner, et al.
Molecular Cell
|
July 11, 2008
Kinase activation and transformation by NUP214-ABL1 is dependent on the context of the nuclear pore
Kim De Keersmaecker, Jennifer L Rocnik, Rafael Bernad, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 28, 2006
Cdx4 dysregulates Hox gene expression and generates acute myeloid leukemia alone and in cooperation with Meis1a in a murine model
Dimple Bansal, Claudia Scholl, Stefan Fröhling, et al.
Nature
|
July 25, 2006
Transformation from committed progenitor to leukaemia stem cell initiated by MLL-AF9
Andrei V Krivtsov, David Twomey, Zhaohui Feng, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
May 29, 2002
A murine model of CML blast crisis induced by cooperation between BCR/ABL and NUP98/HOXA9
Ajeeta B Dash, Ifor R Williams, Jeffery L Kutok, et al.
Blood
|
March 24, 2005
Loss of Runx1 perturbs adult hematopoiesis and is associated with a myeloproliferative phenotype
Joseph D Growney, Hirokazu Shigematsu, Zhe Li, et al.
Nature Medicine
|
July 27, 2004
Mouse model of Noonan syndrome reveals cell type- and gene dosage-dependent effects of Ptpn11 mutation
Toshiyuki Araki, M Golam Mohi, Fraz A Ismat, et al.
Blood Advances
|
March 26, 2020
Runx1 negatively regulates inflammatory cytokine production by neutrophils in response to Toll-like receptor signaling
Dana C Bellissimo, Chia-Hui Chen, Qin Zhu, et al.
Blood
|
January 8, 2003
A model of APL with FLT3 mutation is responsive to retinoic acid and a receptor tyrosine kinase inhibitor, SU11657
Jastinder Sohal, Vernon T Phan, Philip V Chan, et al.
Page
of 19